SOL S.p.A. Share Price

Equities

SOL

IT0001206769

Commodity Chemicals

Market Closed - Borsa Italiana 09:14:59 31/05/2024 pm IST 5-day change 1st Jan Change
33.4 EUR -.--% Intraday chart for SOL S.p.A. +7.74% +20.14%

Financials

Sales 2024 * 158.6Cr 172.19Cr 14TCr Sales 2025 * 170.5Cr 185.11Cr 15TCr Capitalization 302.94Cr 328.9Cr 27TCr
Net income 2024 * 16Cr 18Cr 1.47TCr Net income 2025 * 17Cr 19Cr 1.57TCr EV / Sales 2024 * 2.2 x
Net Debt 2024 * 46Cr 50Cr 4.15TCr Net Debt 2025 * 48Cr 53Cr 4.39TCr EV / Sales 2025 * 2.06 x
P/E ratio 2024 *
18.8 x
P/E ratio 2025 *
17.5 x
Employees 6,372
Yield 2024 *
1.35%
Yield 2025 *
1.44%
Free-Float 36.98%
More Fundamentals * Assessed data
Dynamic Chart
1 week+7.74%
1 month-4.71%
3 months+15.37%
6 months+23.93%
Current year+20.14%
More quotes
1 week
30.45
Extreme 30.45
33.40
1 month
30.30
Extreme 30.3
35.10
Current year
25.60
Extreme 25.6
36.35
1 year
24.00
Extreme 24
36.35
3 years
15.12
Extreme 15.12
36.35
5 years
8.00
Extreme 8
36.35
10 years
5.65
Extreme 5.65
36.35
More quotes
Managers TitleAgeSince
Chief Executive Officer 62 04/90/04
Chief Executive Officer 66 15/90/15
Investor Relations Contact - -
Members of the board TitleAgeSince
Chief Executive Officer 62 04/90/04
Director/Board Member 65 27/98/27
Director/Board Member 62 -
More insiders
Date Price Change Volume
31/24/31 33.4 +4.37% 97,963
30/24/30 32 +3.73% 23,304
29/24/29 30.85 -0.96% 24,524
28/24/28 31.15 +0.48% 25,045
27/24/27 31 -.--% 15,943

Real-time Borsa Italiana, May 31, 2024 at 09:14 pm IST

More quotes
SOL SpA is an Italy-based company primarily engaged in the research, production and distribution of industrial, pure and medicinal gases. It is also involved in the home care medical business. The Company’s product portfolio includes oxygen, nitrogen, hydrogen, argon, sulfur hexafluoride, carbon dioxide, ozone, helium and mixtures of medicinal gases, among others. Through its subsidiaries, the Company is involved in the provision of home care services, such as oxygen therapy, mechanical ventilation, diagnosis and care of obstructive sleep apnea syndrome, artificial nutrition, telemedicine, health assistance, and the prevention and treatment of skin ulcers. Additionally, it is engaged in the supply and management of medical and technological devices for home care. As of December 31, 2011, the Company had a number of subsidiaries, including Airsol BV, Biotechsol Srl, CTS Srl, Energetika ZJ doo, GTH Gaze Industriale SA, Cryolab Srl, GTS Shpk and Hydroenergy Shpk, among others.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
33.4 EUR
Average target price
38 EUR
Spread / Average Target
+13.77%
Consensus

Annual profits - Rate of surprise